Clinical TrialsSearch results
Number of results: 482
Other
- Multi-institute randomized study of natural type interferon alpha for patients with renal cell carcinoma after radical nephrectomy
- Renal cell carcinoma
- TRAIn-Alpha study group
- 2005-09-30
Recruiting
- pembrolizumab plus axitinib trial
- renal cell carcinoma
- Takehiro Iawata
- 2021-03-16
Other
- A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
- Relapsed/Refractory Small Cell Lung Cancer
- Tagashira Shuzo
- 2022-02-19
Other
- Allogeneic stem cell transplantation following reduced-intensity conditioning for relapsed/refractory peripheral T-cell non-Hodgkin's lymphomas
- relapsed/refractory peripheral T-cell non-Hodgkin's lymphomas
- West Japan Hematology Oncology Group/ Hematological Malignancy Therapy Study Group/ Japan Study Group for Cell Therapy and Transplantation
- 2008-11-07
Recruiting
- Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma
- Relapsed/refractory follicular lymphoma
- Asou Hiroya
- 2024-01-31
Recruiting
- Study of KTE-X19 in Adult Japanese Subjects with Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
- Relapsed/Refractory (r/r) Mantle Cell Lymphoma or r/r B-precursor Acute Lymphoblastic Leukemia
- Asou Hiroya
- 2024-01-30
Other
- A combination phase I/II study of topotecan with carboplatin for relapsed small cell lung cancer
- relapsed small cell lung cancer
- West Japan Oncology Group
- 2005-09-07
Recruiting
- A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 in Participants With Relapsed or Refractory T-cell Lymphomas in Japan
- Relapsed or Refractory T-cell Lymphoma
- Hayakawa Jin
- 2023-09-27
Other
- Phase II study of erlotinib monotherapy for relapsed patients with non-small-cell lung cancer who do not possess any active EGFR gene mutations
- relapsed non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2008-11-16
Other
- Phase II study of irinotecan and amrubicin for relapsed non-small-cell lung cancer
- Relapsed non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12